Based on a review of this drug by the National Academy of Sciences - National Research Council and/or other information, FDA has classified the indications as follows:
Effective: Management of nausea and vomiting, and dizziness associated with motion sickness.
Final classification of the less than effective indications requires further investigation.
DOSAGE AND ADMINISTRATION
For the control of vertigo associated with diseases affecting the vestibular system, the recommended dose is 25 to 100 mg daily, in divided dosage, depending upon clinical response.
The initial dose of 25 to 50 mg of Antivert should be taken one hour prior to embarkation for protection against motion sickness. Thereafter, the dose may be repeated every 24 hours for the duration of the journey.
Antivert®: 12.5 mg tablets: Bottles of 100 (NDC 0049-2100-66)
Antivert®/25: 25 mg tablets: Bottles of 100 (NDC 0049-2110-66)
Antivert®/50: 50 mg tablets: Bottles of 100 (NDC 0049-2140-66)
Distributed by: Roerig Division of Pfizer Inc, NY, NY 10017. October 2012
Last reviewed on RxList: 11/2/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Antivert Information
Antivert - User Reviews
Antivert User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.